Jul 21, 2020   SOURCE: PR NewsWire

Infectious Disease Diagnostics Market Size to Reach over $24 Billion by 2025 - Arizton

CHICAGO, July 21, 2020 /PRNewswire/ -- The global infectious disease diagnostics market size is expected to grow at a CAGR of over 7% during the period 2019-2025.

https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

Key Highlights Offered in the Report: 

    1. The US is the major contributor in the global infectious disease
       diagnostics market and is likely to witness an incremental growth rate of
       around $1 billion during the forecast period.
    2. Consumables accounted for a majority share of around 74% and is growing
       at a CAGR of over 8% during 2019-2025.
    3. The hospital segment accounted for majority of the market share, however
       the standard reference laboratory is growing at a faster CAGR of over 7%,
       as the number of standard reference laboratory roles in diagnosis is
       increasing among the developing countries, expected to have absolute
       growth of more than 55%.
    4. The traditional test type dominated the market with around 66% share,
       however the molecular diagnostics with its faster and accurate diagnostic
       feature is growing at a faster rate, slowly replacing traditional
       procedures and the adoption of the molecular diagnostics are increasing
       among various end-users.
    5. Human papillomavirus (HPV) segment dominated the market, which is one of
       the most common sexually transmitted infections and molecular diagnostic
       tests are becoming a promising tool for the diagnosis of this disease.
    6. Various vendors are actively engaged in the development of the new
       product and launching advanced test kits for the diagnosis of the
       diseases at a faster and quicker rate.

Key Offerings: 

    --  Market Size & Forecast by Revenue | 2019-2025
    --  Market Dynamics - Leading trends, growth drivers, restraints, and
        investment opportunities
    --  Market Segmentation - A detailed analysis by products, disease,
        end-user, tests, and geography
    --  Competitive Landscape - 9 key vendors and 15 other vendors

Get your sample today! https://www.arizton.com/market-reports/infectious-disease-diagnostics-market

Infectious Disease Diagnostics Market - Segmentation

    --  In 2019, the traditional diagnostics segment accounted for 66% of the
        infectious disease diagnostics market share. The segment is growing at a
        moderate rate than molecular diagnostics. Conventional diagnostics
        include immunodiagnostics, blood culture tests, and clinical,
        microbiological methods to diagnose several diseases.
    --  The hepatitis segment is likely to grow at a CAGR of over 4% during the
        period 2019-2025. The staggering rise in liver damage cases due to viral
        infections, drug, and chemical abuses, and an increase in alcohol
        intake, is contributing to the growth of the segment. The presence of a
        high pool of infected patients who are undiagnosed and need urgent
        diagnosis is another driver influencing the segment growth.
    --  The hospital end-user segment dominated the infectious disease
        diagnostics market shares. It accounted for the highest market share of
        over 34% in 2019 due to the high volume of infectious disease diagnosis
        and treatment performed in these settings. The increase in the number of
        private hospitals, which have their central laboratories performing a
        high volume of tests, is a major factor influencing the market growth.

Infectious Disease Diagnostics Market by Products 

    --  Instruments/ Analyzers and Software
    --  Consumables

Infectious Disease Diagnostics Market by Disease 

    --  Hepatitis
    --  AIDS
    --  HAIs
    --  Influenza
    --  Tuberculosis
    --  Malaria
    --  HPV Infection
    --  Sepsis
    --  Dengue
    --  Other Diseases

Infectious Disease Diagnostics Market by End-user 

    --  Hospitals
    --  Standard Reference Laboratories
    --  Public Health Laboratories
    --  Blood Banks
    --  Acute Care Settings
    --  Others

Infectious Disease Diagnostics Market by Test

    --  Traditional Diagnostics
    --  Molecular Diagnostics

Infectious Disease Diagnostics Market - Geography

APAC is expected to be the fastest-growing region during the forecast period. This is attributed to the increasing target pool of people requiring various infectious disease diagnostics and improvement in healthcare infrastructure. Moreover, the rising purchasing power of the public for healthcare services and growing focus on early diagnosis and preventive medicine is encouraging many people in the region to undergo diagnostics. China, Japan, India, South Korea, and Australia are the major revenue contributors to the APAC market.

Get your sample today! https://www.arizton.com/market-reports/infectious-disease-diagnostics-market

Infectious Disease Diagnostics Market by Geography

    --  North America
        --  US
        --  Canada
    --  Europe
        --  UK
        --  Germany
        --  France
        --  Italy
        --  Spain
    --  APAC
        --  China
        --  Japan
        --  South Korea
        --  Australia
        --  India
    --  Latin America
        --  Brazil
        --  Mexico
        --  Argentina
    --  Middle East & Africa
        --  South Africa
        --  Saudi Arabia
        --  Turkey
        --  Iran

Prominent Vendors

    --  Abbott
    --  BD
    --  bioMérieux
    --  Hoffmann-La Roche
    --  Thermo Fisher Scientific
    --  Quidel
    --  Luminex
    --  Danaher
    --  Bio-Rad Laboratories

Other Prominent Vendors 

    --  Meridian Bioscience
    --  DiaSorin Molecular
    --  Accelerate Diagnostics
    --  Trinity Biotech
    --  OpGen
    --  QIAGEN
    --  Siemens Healthineers
    --  caviid
    --  EIKEN CHEMICAL
    --  Epitope Diagnostics Inc.
    --  EUROIMMUN
    --  Genetic Signatures
    --  Hologic
    --  Oxford Immunotec
    --  Seegene

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

    --  U.S. Connected Care Market - Industry Outlook and Forecast 2020-2025
    --  Telehealth Market - Global Outlook and Forecast 2020-2025
    --  Remote Healthcare (mHealth, Tele-ICUs, & Virtual Health) Market - Global
        Outlook and Forecast 2020-2025
    --  Nebulizer Market - Global Outlook and Forecast 2020-2025

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: enquiry@arizton.com
Call: +1-312-235-2040
+1 302 469 0707

View original content:http://www.prnewswire.com/news-releases/infectious-disease-diagnostics-market-size-to-reach-over-24-billion-by-2025--arizton-301096971.html

SOURCE Arizton Advisory & Intelligence